Loading chat...
NH SB256
Bill
AI Summary
-
Requires written agreements between healthcare providers and pharmacies before insurers or pharmacy benefit managers (PBMs) can mandate "white bagging" (delivering drugs to providers for administration), including provider consent
-
Prohibits mandatory "brown bagging" (patients transporting drugs to providers) unless both patient and provider provide written consent and attest that transport will not compromise care
-
Prevents insurers and PBMs from imposing higher copays, fees, or coinsurance when patients obtain clinician-administered drugs from non-network pharmacies or pharmacies not selected by the insurer
-
Protects providers from reduced reimbursement when they obtain clinician-administered drugs from pharmacies outside the insurer's network or not managed by the PBM
-
Takes effect January 1, 2027, applying to outpatient prescription drugs that cannot be self-administered and must be given by a healthcare professional in a clinical setting
Legislative Description
Establishing safety and care requirements for clinician-administered drugs.
Last Action
Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): Motion Adopted Voice Vote (in recess of) 02/19/2026 House Journal 5
3/2/2026